The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Applied Survival Analysis: Regression Modeling of Time-to-Event Data
Hosmer, D. W., Lemeshow, S. A., & May, S. J. (2008) · Cited by 3,030
Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study.
SERVICE, F. J., McMAHON, M. M., O'BRIEN, P. C., & BALLARD, D. J. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62083-7 · Cited by 883 · cited 1×
“The SEER registry does not include benign insulinomas but given their very favorable prognosis [16], it seems reasonable to exclude them from this analysis.”
Applied Survival Analysis: Regression Modeling of Time to Event Data
Rao, P. V., Hosmer, D. W., & Lemeshow, S. (2000) · Journal of the American Statistical Association · doi:10.2307/2669422 · Cited by 861
Sarmiento, J. M., Heywood, G., Rubin, J., Ilstrup, D. M., Nagorney, D. M., & Que, F. G. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00230-8 · Cited by 773
Self-citationCronin, K. A., Ries, L. A. G., & Edwards, B. K. (2014) · Cancer · doi:10.1002/cncr.29049 · Cited by 699
Neuroendocrine Hepatic Metastases: Does Aggressive Management Improve Survival?
Touzios, J. G., Kiely, J. M., Pitt, S. C., Rilling, W. S., Quebbeman, E. J., Wilson, S. D., & Pitt, H. A. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000161981.58631.ab · Cited by 362
Rationale for the use of somatostatin analogs as antitumor agents
Susini, C., & Buscail, L. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl105 · Cited by 304
Differences in Survival by Histologic Type of Pancreatic Cancer
Fesinmeyer, M. D., Austin, M. A., Li, C. I., De Roos, A. J., & Bowen, D. J. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0120 · Cited by 270
Clinical pathology of endocrine tumors of the pancreas: Analysis of autopsy cases
Kimura, W., Kuroda, A., & Morioka, Y. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01297144 · Cited by 259
Islet cell carcinomas of the pancreas: a twenty-year experience.
Thompson, G. B., van Heerden, J. A., Grant, C. S., Carney, J. A., & Ilstrup, D. M. (1988) · PubMed · Cited by 249
Klöppel, G., & Heitz, P. U. (1988) · Pathology - Research and Practice · doi:10.1016/s0344-0338(88)80043-8 · Cited by 248
Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients
Phan, G. Q., Yeo, C. J., Hruban, R. H., Lillemoe, K. D., Pitt, H. A., & Cameron, J. L. (1998) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(98)80039-5 · Cited by 239
Hepatic surgery for metastases from neuroendocrine tumors
Sarmiento, J. M., & Que, F. G. (2003) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00076-5 · Cited by 227
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours
Aparicio, T., Ducreux, M., Baudin, E., Sabourin, J.-C., De Baere, T., Mitry, E., Schlumberger, M., & Rougier, P. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00073-9 · Cited by 226
Schurr, P. G., Strate, T., Rese, K., Kaifi, J. T., Reichelt, U., Petri, S., Kleinhans, H., Yekebas, E. F., & Izbicki, J. R. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000232556.24258.68 · Cited by 178
Non-Islet Origin of Pancreatic Islet Cell Tumors
Vortmeyer, A. O., Huang, S., Lubensky, I., & Zhuang, Z. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031575 · Cited by 166
Lepage, C., Bouvier, A., Phelip, J. M., et al. (2004) · Gut · doi:10.1136/gut.2003.026401 · Cited by 146
Epidemiology of Pancreatic Cancer in Connecticut
Moldow, R. E., & Connelly, R. R. (1968) · Gastroenterology · doi:10.1016/s0016-5085(19)33985-x · Cited by 137
Lam, A. K.-Y., & Lo, C. Y. (1997) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(97)80140-0 · Cited by 129
Neuroendocrine Pancreatic Tumors Clinical Findings in a prospective study of 84 patients
Eriksson, B. K., Ouberg, K., & Skogseid, B. M. (1989) · Acta Oncologica · doi:10.3109/02841868909111209 · Cited by 128
Biotherapy for metastatic endocrine tumours
Shah, T., & Caplin, M. E. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.02.012 · Cited by 55
Cited by
Dasari, A., Shen, C., Halperin, D., Zhao, B., Zhou, S., Xu, Y., Shih, T., & Yao, J. C. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0589 · Cited by 3,447
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Raymond, E., Dahan, L., Raoul, J.-L., Bang, Y.-J., Borbath, I., Lombard-Bohas, C., Valle, J., Metrakos, P., Smith, D., Vinik, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1003825 · Cited by 2,567
Falconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Pavel, M., Baudin, E., Couvelard, A., Krenning, E., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B., & Salazar, R. (2012) · Neuroendocrinology · doi:10.1159/000335597 · Cited by 873
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Shah, M. H., Goldner, W. S., Benson, A. B., Bergsland, E., Blaszkowsky, L. S., Brock, P., Chan, J., Das, S., Dickson, P. V., Fanta, P., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0032 · Cited by 619
Self-citation
Metadata
- Authors
- Halfdanarson, T. R., Rabe, K. G., Rubin, J., & Petersen, G. M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 19
- Issue
- 10
- Pages
- 1727-1733
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2160463900
- Cited by
- 892
- References
- 21
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.